Do patients with mental disorders experience disparities in the screening and treatment of cardiovascular diseases?
There are significant global disparities in cardiovascular care for patients with mental disorders, highlighting a critical need to address underprescribing and underutilization of CVD diagnostics and therapies in this population.
People with mental disorders, and those with schizophrenia in particular, receive less screening and lower-quality treatment for CVD. It is of paramount importance to address underprescribing of CVD medications and underutilization of diagnostic and therapeutic procedures across all mental disorders.
Solmi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: